Tuoxin Pharmaceutical
SZSE · 301089
Market Cap$2.8B
Revenue$373.9M
Employees1543
Listed OnSZSE
Ticker301089
CEO / ExecMr. Shaohua Yang
HeadquartersXinxiang
MarketMainland China
Websitewww.tuoxinpharm.com
Overview
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.